Detalhe da pesquisa
1.
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
J Infect Dis
; 215(11): 1711-1719, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591778
2.
Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9-14 Years Versus a 3-Dose Regimen in Women Aged 15-25 Years.
J Infect Dis
; 214(4): 525-36, 2016 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908726
3.
Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine.
Vaccine
; 37(9): 1209-1218, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30691980
4.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50â¯years of age: A randomized trial.
Vaccine
; 36(29): 4278-4286, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903674
5.
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.
Vaccine
; 35(15): 1865-1872, 2017 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302407
6.
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
Vaccine
; 35(10): 1431-1439, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187952
7.
Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.
Hum Vaccin Immunother
; 12(8): 2197-2203, 2016 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27123743
8.
Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50â¯years of age: A randomized trial' [Vaccine 36 (2018) 4278-4286].
Vaccine
; 37(9): 1252-1253, 2019 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711316